Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) Operating cash flow

Alert me on Operating cash flow

Bio-Techne Corp's operating cash flow for fiscal 2026 was $292.1M, unchanged from fiscal 2025. Over the past ten years it has ranged from $139.4M (fiscal 2015) to $352.2M (fiscal 2021); the current reading is higher than 75% of that period. Bio-Techne Corp ranks 17th of 611 Biotechnology companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2026 $292.1M 1.57%
FY2025 $287.6M (3.82%)
FY2024 $299.0M 17.53%
FY2023 $254.4M (21.79%)
FY2022 $325.3M (7.64%)
FY2021 $352.2M 71.61%
FY2020 $205.2M 12.99%
FY2019 $181.6M 6.60%
FY2018 $170.4M 18.54%
FY2017 $143.7M (0.30%)

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $95.4M 10.10%
Mar 2026 $86.7M 5.16%
Dec 2025 $82.4M 198.75%
Sep 2025 $27.6M (71.91%)
42 more quarters

Against its own ten years

Low $139.4M High $352.2M
Ten-year median $229.8M
Current reading's percentile 75

Operating cash flow against peers

Company Operating cash flow
BMRN BioMarin Pharmaceutical Inc. compare $857.1M
TECH Bio-Techne Corp $292.1M
KRYS Krystal Biotech, Inc. compare $272.3M
CORT Corcept Therapeutics Incorporated compare $109.7M
MDGL Madrigal Pharmaceuticals, Inc. compare −$197.7M
IBRX ImmunityBio, Inc. compare −$281.1M
BBIO BridgeBio Pharma, Inc. compare −$434.4M
SMMT Summit Therapeutics PLC compare −$458.4M
PCVX Vaxcyte, Inc. compare −$881.2M

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on TECH